Heat Waves and the Elderly - Cooling Modalities
Heat Waves in the Elderly: Reducing Thermal and Cardiovascular Consequences
1 other identifier
interventional
100
1 country
1
Brief Summary
The purpose of this study is to assess how well cooling modalities work in reducing cardiovascular stress of the elderly to heat wave conditions
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 27, 2022
CompletedFirst Posted
Study publicly available on registry
August 2, 2022
CompletedStudy Start
First participant enrolled
February 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2026
October 23, 2025
October 1, 2025
3.5 years
July 27, 2022
October 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in core body temperature
Change in core body temperature will be measured either from a temperature sensor pill or from a rectal thermometer
Body core temperature will be obtained within 60 min before the heat wave exposure after the 3 hour heat wave exposure.
Change in left ventricular function
Measures of left ventricular function, such as ventricular wall motion and ventricular filling, will be obtained from echocardiography images.
Within 60 minutes before each simulated heat wave exposure, around minute 90 of the heat wave exposure, and at the end of the 3 hour heat wave exposure
Secondary Outcomes (12)
Heart rate
Prior to and throughout each simulated heat wave exposure; approximately 420 minutes
Cardiac output
Within 60 minutes before each simulated heat wave exposure and during each simulated heat wave exposure (up to 3 hours)
Arterial blood pressure
Prior to and throughout each simulated heat wave exposure; an average of 480 minutes
Whole body sweat rate
Within 60 minutes before each simulated heat wave exposure and within 30 minutes after each heat wave exposure.
Markers of renal function and injury - Cystatin C
Within 60 minutes before each simulated heat wave exposure, during each simulated heat wave exposure (up to 3 hours), and within 2 hours after the simulated heat wave exposure
- +7 more secondary outcomes
Study Arms (2)
Very hot and dry
EXPERIMENTALSubjects will be exposed to 3 hours in a climate chamber set to approximately 47 deg C and 15% relative humidity, which reflects a very hot and dry heat wave condition similar to the 2018 Los Angeles heat wave. Four visits will be required to complete this arm, with each visit a different cooling modality applied.
Hot and humid
EXPERIMENTALSubjects will be exposed to 3 hours in a climate chamber set to approximately 41 deg C and 40% relative humidity, which reflects hot and humid heat wave similar to the 1995 Chicago heat wave. Four visits will be required to complete this arm, with each visit a different cooling modality applied.
Interventions
Participants will receive water spraying on their body throughout the climate chamber exposure.
Participants will be exposed to a fan throughout the climate chamber exposure.
Participants will receive both water spraying and a fan throughout the climate chamber exposure.
Participants will NOT receive either water spray or a fan exposure.
Eligibility Criteria
You may qualify if:
- years of age or older
- Free of any significant underlying medical problems based upon a detailed medical history and physical exam
You may not qualify if:
- Known heart disease
- Other chronic medical conditions requiring regular medical therapy including cancer, diabetes, uncontrolled hypertension, and uncontrolled hypercholesterolemia etc;
- Abnormality detected on routine screening suggestive of provokable ischemia or previously undetected cardiac disease or resting left bundle branch block on screening electrocardiogram.
- Current smokers, as well as individuals who regularly smoked within the past 3 years
- Subject with a body mass index ≥31 kg/m2
- Pregnant individuals
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Texas Health Presbyterian Hospital Dallas
Dallas, Texas, 75231, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Internal Medicine
Study Record Dates
First Submitted
July 27, 2022
First Posted
August 2, 2022
Study Start
February 21, 2023
Primary Completion (Estimated)
August 31, 2026
Study Completion (Estimated)
August 31, 2026
Last Updated
October 23, 2025
Record last verified: 2025-10